Hisamitsu Pharmaceutical Co (TSE:4530) Tariff Resilience Score : 5/10 (As of Jul. 21, 2025)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Tariff Resilience Score?

Hisamitsu Pharmaceutical Co has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

Hisamitsu Pharmaceutical Co has Hisamitsu Pharmaceutical Co Inc faces moderate tariff risks due to its global supply chain for pharmaceutical products. While it has some pricing power, changes in trade policies can affect costs and market access.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Hisamitsu Pharmaceutical Co might have Average Resilient.

Competitive Comparison of Hisamitsu Pharmaceutical Co's Tariff Resilience Score

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hisamitsu Pharmaceutical Co's Tariff Resilience Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Tariff Resilience Score falls into.

Save Embed

;

Save Embed

;

Hisamitsu Pharmaceutical Co (TSE:4530) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score	Resilience Level
7 - 10	Highly Resilient
4 - 6	Average Resilient
0 - 3	Highly Vulnerable

Hisamitsu Pharmaceutical Co Tariff Resilience Score Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Tariff Resilience Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Tariff Resilience Score

Comparable Companies

Traded in Other Exchanges

HTSUF:USA HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co Headlines

No Headlines